Comparison of Transplacental Treatment of Fetal Supraventricular Tachyarrhythmias With Digoxin, Flecainide, and Sotalol | Zendy

Edgar Jaeggi | Zendy; J. S. Carvalho | Zendy; Ernestine De Groot | Zendy; Oluş Api | Zendy; Sally-Ann B. Clur | Zendy; Lukas Rammeloo | Zendy; Brian W. McCrindle | Zendy; Greg Ryan | Zendy; Cedric Manlhiot | Zendy; Nico A. Blom | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Comparison of Transplacental Treatment of Fetal Supraventricular Tachyarrhythmias With Digoxin, Flecainide, and Sotalol

Author(s) -

Edgar Jaeggi,

J. S. Carvalho,

Ernestine De Groot,

Oluş Api,

Sally-Ann B. Clur,

Lukas Rammeloo,

Brian W. McCrindle,

Greg Ryan,

Cedric Manlhiot,

Nico A. Blom

Publication year - 2011

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.111.026120

Subject(s) - flecainide , medicine , sotalol , digoxin , cardiology , atrial flutter , supraventricular tachycardia , sinus rhythm , cardioversion , tachycardia , transplacental , anesthesia , fetus , atrial fibrillation , heart failure , pregnancy , biology , placenta , genetics

Fetal tachyarrhythmia may result in low cardiac output and death. Consequently, antiarrhythmic treatment is offered in most affected pregnancies. We compared 3 drugs commonly used to control supraventricular tachycardia (SVT) and atrial flutter (AF).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research